Literature DB >> 16319502

Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes.

Mogher Khamaisi1, Shoshana Keynan, Michael Bursztyn, Rachel Dahan, Etti Reinhartz, Haim Ovadia, Itamar Raz.   

Abstract

BACKGROUND: Several studies have suggested that an early increase in renal nitric oxide (NO) production or activity mediates pathophysiologic and morphologic changes in diabetic nephropathy. To evaluate the role of NO in developing diabetic kidney disease, we studied the NO system in streptozotocin (STZ)-induced diabetic rats for a period of 8 weeks.
METHODS: Control rats, STZ-induced diabetic rats, and STZ-induced diabetic rats treated with insulin were monitored and sacrificed at 1, 2, and 8 weeks. Urinary cGMP was measured, and the levels and activity of NO synthase (NOS) isoforms in the kidney cortex were determined at specific times by immunoblotting and diaphorase staining.
RESULTS: Diabetic rats had increased kidney weight, urinary volume, glucose, sodium and potassium excretion, which was precluded by insulin treatment. Creatinine clearance was increased in the diabetic group and reversed by insulin treatment. Urinary cGMP decreased by 71, 93, and 92% at 1, 2, and 8 weeks of diabetes, respectively, compared with the control animals. Insulin treatment curtailed the urinary cGMP reduction in diabetic animals. Total NOS activity in the renal cortex was reduced by 65, 52, and 44% after 1, 2, and 8 weeks of diabetes, respectively, and returned to normal levels upon insulin treatment. NADPH diaphorase staining of renal cortical slices showed a 77, 63, and 70% decrease in neuronal NOS isoform activity in the macula densa after 1, 2, and 8 weeks of diabetes, respectively, compared with control non-diabetic animals. This reduction was normalized by insulin treatment. Endothelial NOS protein expression in the kidney cortex tended to increase after 1 week of diabetes and its level was elevated significantly after 2 and 8 weeks of diabetes. However, neuronal NOS protein expression in the kidney cortex was reduced by 52% in 2-week diabetic animals, but this reduction was normalized by insulin treatment.
CONCLUSIONS: The decreased renal NOS activity during the late phase of diabetes is partially associated with a decrease in neuronal NOS activity and protein expression in kidney macula densa. 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319502     DOI: 10.1159/000089946

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  9 in total

1.  Effects of panax quinquefolium on streptozotocin-induced diabetic rats: role of C-peptide, nitric oxide and oxidative stress.

Authors:  Kamal Adel Amin; Ezzat Mohamed Awad; Mohammed Ahmad Nagy
Journal:  Int J Clin Exp Med       Date:  2011-02-26

2.  The expanding roles of neuronal nitric oxide synthase (NOS1).

Authors:  Kundan Solanki; Sajjan Rajpoot; Evgeny E Bezsonov; Alexander N Orekhov; Rohit Saluja; Anita Wary; Cassondra Axen; Kishore Wary; Mirza S Baig
Journal:  PeerJ       Date:  2022-07-07       Impact factor: 3.061

3.  Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney.

Authors:  Ildikó Toma; Jung Julie Kang; Arnold Sipos; Sarah Vargas; Eric Bansal; Fiona Hanner; Elliott Meer; János Peti-Peterdi
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

4.  Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy.

Authors:  Shinichi Okada; Motoaki Saito; Emi Kazuyama; Takuya Hanada; Yasuo Kawaba; Atsushi Hayashi; Keisuke Satoh; Susumu Kanzaki
Journal:  Mol Cell Biochem       Date:  2008-06-05       Impact factor: 3.396

5.  Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy.

Authors:  Wim Scheele; Susan Diamond; Jeremy Gale; Valerie Clerin; Nihad Tamimi; Vu Le; Rosalind Walley; Fernando Grover-Páez; Christelle Perros-Huguet; Timothy Rolph; Meguid El Nahas
Journal:  J Am Soc Nephrol       Date:  2016-04-25       Impact factor: 10.121

6.  Correlation of Endothelial Nitric Oxide Synthase Gene Polymorphism (GG, TT and GT Genotype) with Proteinuria and Retinopathy in Type 2 Diabetic Patients.

Authors:  Ali Momeni; Morteza Hashemzadeh Chaleshtori; Saeed Saadatmand; Soleiman Kheiri
Journal:  J Clin Diagn Res       Date:  2016-02-01

7.  Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.

Authors:  David Z I Cherney; Heather N Reich; Shan Jiang; Ronnie Har; Rania Nasrallah; Richard L Hébert; Vesta Lai; James W Scholey; Etienne B Sochett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-01       Impact factor: 3.619

8.  Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.

Authors:  Shaojiang Tian; Junming Tang; Huihui Liu; Liping Wang; Jianming Shen; Junfeng Li; Yanjie Gan
Journal:  Exp Diabetes Res       Date:  2012-09-04

9.  Nitric Oxide Gene Polymorphism is a Risk Factor for Diabetic Nephropathy and Atherosclerosis in Type 1 Diabetic Patients.

Authors:  Soha M Abd El Dayem; Ahmed A Battah; Abo El Maged El Bohy; Solaf Ahmed; Mona Hamed; Safa Nabil Abd El Fattah
Journal:  Open Access Maced J Med Sci       Date:  2019-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.